BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493-508. [PMID: 19841322 DOI: 10.1200/jco.2009.23.4450] [Cited by in Crossref: 305] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zdenkowski N, Chen S, van der Westhuizen A, Ackland S. Curative strategies for liver metastases from colorectal cancer: a review. Oncologist. 2012;17:201-211. [PMID: 22234631 DOI: 10.1634/theoncologist.2011-0300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
3 Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int 2014;2014:340478. [PMID: 24868526 DOI: 10.1155/2014/340478] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Eadens MJ, Grothey A. Curable metastatic colorectal cancer. Curr Oncol Rep. 2011;13:168-176. [PMID: 21298372 DOI: 10.1007/s11912-011-0157-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
5 Castellanos JA, Merchant NB. Strategies for Management of Synchronous Colorectal Metastases. Curr Surg Rep. 2014;2:62. [PMID: 25431745 DOI: 10.1007/s40137-014-0062-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Feng Y, Mo S, Dai W, Li Q, Cai G, Cai S. Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study. Int J Clin Oncol 2020;25:100-9. [PMID: 31531787 DOI: 10.1007/s10147-019-01538-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Perera RH, Solorio L, Wu H, Gangolli M, Silverman E, Hernandez C, Peiris PM, Broome AM, Exner AA. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Pharm Res 2014;31:1407-17. [PMID: 23943542 DOI: 10.1007/s11095-013-1100-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
8 Leite D, Kater FR. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX. Anticancer Drugs 2011;22 Suppl 2:S1-7. [PMID: 21768791 DOI: 10.1097/01.cad.0000398726.60837.27] [Reference Citation Analysis]
9 Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis. Eur J Surg Oncol 2014;40:536-44. [PMID: 24555996 DOI: 10.1016/j.ejso.2014.01.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 8.5] [Reference Citation Analysis]
10 Karanicolas PJ, Jarnagin WR, Gonen M, Tuorto S, Allen PJ, DeMatteo RP, D'Angelica MI, Fong Y. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597-601. [PMID: 23699996 DOI: 10.1001/jamasurg.2013.1431] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
11 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
12 Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pelley R, Siperstein AE, Berber E. Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg 2013;37:1333-9. [PMID: 23460452 DOI: 10.1007/s00268-013-1981-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
13 Ong SL, Gravante G, Metcalfe MS, Dennison AR. History, ethics, advantages and limitations of experimental models for hepatic ablation. World J Gastroenterol 2013; 19(2): 147-154 [PMID: 23345935 DOI: 10.3748/wjg.v19.i2.147] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Macedo FIB, Makarawo T. Colorectal hepatic metastasis: Evolving therapies. World J Hepatol 2014; 6(7): 453-463 [PMID: 25067997 DOI: 10.4254/wjh.v6.i7.453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
15 Stang A, Donati M, Weilert H, Oldhafer KJ. Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases. J Cancer 2016;7:1939-49. [PMID: 27877209 DOI: 10.7150/jca.15656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Knott EA, Ziemlewicz TJ, Lubner SJ, Swietlik JF, Weber SM, Zlevor AM, Longhurst C, Hinshaw JL, Lubner MG, Mulkerin DL, Abbott DE, Deming D, LoConte NK, Uboha N, Couillard AB, Wells SA, Laeseke PF, Alexander ML, Lee FT Jr. Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis. J Gastrointest Oncol 2021;12:1454-69. [PMID: 34532102 DOI: 10.21037/jgo-21-159] [Reference Citation Analysis]
17 Dawood S, Sirohi B, Shrikhande SV, Toh HC, Eng C. Potential Prognostic Impact of Baseline CEA Level and Surgery of Primary Tumor Among Patients with Synchronous Stage IV Colorectal Cancer: A Large Population Based Study. Indian J Surg Oncol 2015;6:198-206. [PMID: 27217664 DOI: 10.1007/s13193-015-0419-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Giglio MC, Logghe B, Garofalo E, Tomassini F, Vanlander A, Berardi G, Montalti R, Troisi RI. Laparoscopic Versus Open Thermal Ablation of Colorectal Liver Metastases: A Propensity Score-Based Analysis of Local Control of the Ablated Tumors. Ann Surg Oncol 2020;27:2370-80. [PMID: 32060758 DOI: 10.1245/s10434-020-08243-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Bahl A, Kapoor R, Singh PK, Bhattacharya T, Arun OS, Parsee T, Sharma SC. Locally ablative non-surgical management of colo-rectal liver metastasis. J Gastrointest Cancer 2013;44:108-10. [PMID: 22864942 DOI: 10.1007/s12029-012-9427-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Chen Y, Xu Y, Xu L, Han F, Huang Y, Jiang H, Wu J, Zhang Y. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study. Front Oncol 2021;11:758552. [PMID: 34745996 DOI: 10.3389/fonc.2021.758552] [Reference Citation Analysis]
21 De Cobelli F, Marra P, Ratti F, Ambrosi A, Colombo M, Damascelli A, Sallemi C, Gusmini S, Salvioni M, Diana P, Cipriani F, Venturini M, Aldrighetti L, Del Maschio A. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art. Med Oncol 2017;34:49. [PMID: 28220346 DOI: 10.1007/s12032-017-0903-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
22 Mitchell D, Puckett Y, Nguyen QN. Literature Review of Current Management of Colorectal Liver Metastasis. Cureus. 2019;11:e3940. [PMID: 30937238 DOI: 10.7759/cureus.3940] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Guo H, Huang J, Tan Y, Wu W, Huang T, Zhang N, Chen S, Zhang C, Xie X, Shuai X, Xu M. Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation. Nano Today 2022;43:101425. [DOI: 10.1016/j.nantod.2022.101425] [Reference Citation Analysis]
24 Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kawano H, Kinugasa Y, Kokudo N, Murofushi K, Nakajima T, Oka S, Sakai Y, Tsuji A, Uehara K, Ueno H, Yamazaki K, Yoshida M, Yoshino T, Boku N, Fujimori T, Itabashi M, Koinuma N, Morita T, Nishimura G, Sakata Y, Shimada Y, Takahashi K, Tanaka S, Tsuruta O, Yamaguchi T, Yamaguchi N, Tanaka T, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1-34. [PMID: 28349281 DOI: 10.1007/s10147-017-1101-6] [Cited by in Crossref: 400] [Cited by in F6Publishing: 364] [Article Influence: 80.0] [Reference Citation Analysis]
25 Meriggi F, Bertocchi P, Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg 2013; 5(5): 138-145 [PMID: 23710291 DOI: 10.4240/wjgs.v5.i5.138] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
26 Sakamoto JH, van de Ven AL, Godin B, Blanco E, Serda RE, Grattoni A, Ziemys A, Bouamrani A, Hu T, Ranganathan SI, De Rosa E, Martinez JO, Smid CA, Buchanan RM, Lee SY, Srinivasan S, Landry M, Meyn A, Tasciotti E, Liu X, Decuzzi P, Ferrari M. Enabling individualized therapy through nanotechnology. Pharmacol Res 2010;62:57-89. [PMID: 20045055 DOI: 10.1016/j.phrs.2009.12.011] [Cited by in Crossref: 136] [Cited by in F6Publishing: 98] [Article Influence: 11.3] [Reference Citation Analysis]
27 Reinhardt M, Brandmaier P, Seider D, Kolesnik M, Jenniskens S, Sequeiros RB, Eibisberger M, Voglreiter P, Flanagan R, Mariappan P, Busse H, Moche M; ClinicIMPPACT Study Group. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT). Contemp Clin Trials Commun 2017;8:25-32. [PMID: 29696193 DOI: 10.1016/j.conctc.2017.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Wang CZ, Yan GX, Xin H, Liu ZY. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases. World J Gastrointest Oncol 2020; 12(9): 1044-1055 [PMID: 33005297 DOI: 10.4251/wjgo.v12.i9.1044] [Reference Citation Analysis]
29 Koopman AGMM, Jenniskens SFM, Fütterer JJ. Magnetic Resonance Imaging Assessment After Therapy in Prostate Cancer. Top Magn Reson Imaging 2020;29:47-58. [PMID: 32015294 DOI: 10.1097/RMR.0000000000000231] [Reference Citation Analysis]
30 Tsoulfas G, Pramateftakis MG, Kanellos I. Surgical treatment of hepatic metastases from colorectal cancer. World J Gastrointest Oncol 2011; 3(1): 1-9 [PMID: 21267397 DOI: 10.4251/wjgo.v3.i1.1] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
31 Binefa G, Rodríguez-Moranta F, Teule &, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine. World J Gastroenterol 2014; 20(22): 6786-6808 [PMID: 24944469 DOI: 10.3748/wjg.v20.i22.6786] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 145] [Article Influence: 19.4] [Reference Citation Analysis]
32 O'Leary C, Soulen MC, Shamimi-Noori S. Interventional Oncology Approach to Hepatic Metastases.Semin Intervent Radiol. 2020;37:484-491. [PMID: 33328704 DOI: 10.1055/s-0040-1719189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Giglio MC, Garofalo E, Montalti R, Vanlander A, Troisi RI. The learning curve of laparoscopic ablation of liver tumors: A technically demanding procedure requiring dedicated training. Eur J Surg Oncol 2021;47:2579-85. [PMID: 34127330 DOI: 10.1016/j.ejso.2021.05.032] [Reference Citation Analysis]
34 Romesser PB, Tyagi N, Crane CH. Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases. Cancers (Basel) 2021;13:1636. [PMID: 33915810 DOI: 10.3390/cancers13071636] [Reference Citation Analysis]
35 Murawa D, Spychała A, Lewandowski A, Nowaczyk P. Laparoscopic thermoablation of colorectal cancer metastases to the liver - new experience of the centre. Contemp Oncol (Pozn) 2012;16:179-83. [PMID: 23788874 DOI: 10.5114/wo.2012.28801] [Reference Citation Analysis]
36 Hooi FM, Nagle A, Subramanian S, Douglas Mast T. Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging. J Acoust Soc Am 2015;137:585-97. [PMID: 25697993 DOI: 10.1121/1.4906580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
37 Pathak S, Dash I, Taylor MR, Poston GJ. An overview of the surgical management of hepatic neuroendocrine metastases. Indian J Surg Oncol 2012;3:20-5. [PMID: 23449915 DOI: 10.1007/s13193-012-0133-7] [Reference Citation Analysis]
38 Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde C, Balmana J, Regula J, Nagtegaal I, Beets-tan R, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne C, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard J, El Ghazaly H, Gallardo J, Garin A, Glynne-jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Annals of Oncology 2012;23:2479-516. [DOI: 10.1093/annonc/mds236] [78495111110.1093/annonc/mds236','', '1007-9327')">Reference Citation Analysis]
39 Kataoka K, Kanazawa A, Iwamoto S, Kato T, Nakajima A, Arimoto A. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease? World J Surg 2014;38:936-46. [PMID: 24166026 DOI: 10.1007/s00268-013-2305-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
40 Desolneux G, Vara J, Razafindratsira T, Isambert M, Brouste V, McKelvie-Sebileau P, Evrard S. Patterns of complications following intraoperative radiofrequency ablation for liver metastases. HPB (Oxford) 2014;16:1002-8. [PMID: 24830798 DOI: 10.1111/hpb.12274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
41 Li J, Zhang L, Xu W, Wang T, Zhou L, Xie Q, Wang W, Hua Y. Computed tomography-guided implantation of 125I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results. J Contemp Brachytherapy 2017;9:132-8. [PMID: 28533801 DOI: 10.5114/jcb.2017.67023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
42 Wijlemans JW, Bartels LW, Deckers R, Ries M, Mali WP, Moonen CT, van den Bosch MA. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours. Cancer Imaging 2012;12:387-94. [PMID: 23022541 DOI: 10.1102/1470-7330.2012.9038] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
43 Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS. Liver resection for colorectal cancer metastases. Curr Oncol. 2013;20:e255-e265. [PMID: 23737695 DOI: 10.3747/co.20.1341] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
44 Ito F, Vardam TD, Appenheimer MM, Eng KH, Gollnick SO, Muhitch JB, Evans SS. In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy. Int J Hyperthermia 2019;36:22-36. [PMID: 31795828 DOI: 10.1080/02656736.2019.1653500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Simo KA, Mckillop IH, Ahrens WA, Martinie JB, Iannitti DA, Sindram D. Invasive biliary mucinous cystic neoplasm: a review. HPB (Oxford) 2012;14:725-40. [PMID: 23043661 DOI: 10.1111/j.1477-2574.2012.00532.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
46 Pinheiro RS, Herman P, Lupinacci RM, Lai Q, Mello ES, Coelho FF, Perini MV, Pugliese V, Andraus W, Cecconello I, D'Albuquerque LC. Tumor growth pattern as predictor of colorectal liver metastasis recurrence. Am J Surg 2014;207:493-8. [PMID: 24112674 DOI: 10.1016/j.amjsurg.2013.05.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
47 Nielsen K, Scheffer HJ, Volders JH, van der Vorst MJ, van Tilborg AA, Comans EF, de Lange-de Klerk ES, Sietses C, Meijer S, Meijerink MR, van den Tol MP. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases. World J Surg 2016;40:1951-8. [PMID: 27220509 DOI: 10.1007/s00268-016-3554-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
48 Sutphin PD, Ganguli S. Interventional Treatment of Hepatic Metastases from Colorectal Cancer. Semin Intervent Radiol 2020;37:492-8. [PMID: 33328705 DOI: 10.1055/s-0040-171919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 van Dams R, Raldow AC, Lee P. Role of MR-guided Radiotherapy (MRgRT) in Colorectal Cancer. Curr Colorectal Cancer Rep 2021;17:69-76. [DOI: 10.1007/s11888-021-00467-6] [Reference Citation Analysis]
50 Stang A, Oldhafer KJ, Weilert H, Keles H, Donati M. Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal. BMC Cancer 2014;14:500. [PMID: 25016394 DOI: 10.1186/1471-2407-14-500] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zhou M, He H, Cai H, Chen H, Hu Y, Shu Z, Deng Y. Diaphragmatic perforation with colonic herniation due to hepatic radiofrequency ablation: A case report and review of the literature. Oncol Lett. 2013;6:1719-1722. [PMID: 24260068 DOI: 10.3892/ol.2013.1625] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
52 Meyer J, Toomay S. Update on treatment of liver metastases: focus on ablation therapies. Curr Oncol Rep. 2015;17:420. [PMID: 25416314 DOI: 10.1007/s11912-014-0420-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Høyer M, Erichsen R, Gandrup P, Nørgaard M, Jacobsen JB. Survival in patients with synchronous liver metastases in central and northern Denmark, 1998 to 2009. Clin Epidemiol 2011;3 Suppl 1:11-7. [PMID: 21814465 DOI: 10.2147/CLEP.S20613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
54 Lin CC, Chen TH, Wu YC, Fang CY, Wang JY, Chen CP, Huang KW, Jiang JK. Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer. Ann Surg Oncol 2021;28:1762-76. [PMID: 32875464 DOI: 10.1245/s10434-020-08914-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Subramanian S, Schmidt DT, Rao MB, Mast TD. Dependence of ultrasound echo decorrelation on local tissue temperature during ex vivo radiofrequency ablation. Phys Med Biol 2016;61:2356-71. [PMID: 26943026 DOI: 10.1088/0031-9155/61/6/2356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
56 Gravante G. Thermal ablation for unresectable liver tumours, time to move forward? World J Gastrointest Surg 2010; 2(1): 1-5 [PMID: 21160826 DOI: 10.4240/wjgs.v2.i1.1] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Carpenter SG, Carson J, Fong Y. Regional liver therapy using oncolytic virus to target hepatic colorectal metastases. Semin Oncol 2010;37:160-9. [PMID: 20494708 DOI: 10.1053/j.seminoncol.2010.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
58 Cheng HY, Huang KW, Liang JT, Lin BR, Huang J, Hung JS, Chen CL. Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer. J Clin Med 2021;10:3712. [PMID: 34442007 DOI: 10.3390/jcm10163712] [Reference Citation Analysis]
59 Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg. 2011;35:656-661. [PMID: 21161655 DOI: 10.1007/s00268-010-0890-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
60 Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 2019;22:284-92. [PMID: 30832966 DOI: 10.1016/j.jval.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Krell RW, Reames BN, Hendren S, Frankel TL, Pawlik TM, Chung M, Kwon D, Wong SL. Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey. Ann Surg Oncol 2015;22:2179-94. [PMID: 25582739 DOI: 10.1245/s10434-014-4318-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
62 You J, Zhang P, Hu F, Du Y, Yuan H, Zhu J, Wang Z, Zhou J, Li C. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy. Pharm Res 2014;31:554-65. [PMID: 24022681 DOI: 10.1007/s11095-013-1180-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
63 Leung U, Kuk D, D'Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 2015;102:85-91. [PMID: 25296639 DOI: 10.1002/bjs.9649] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 8.4] [Reference Citation Analysis]
64 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
65 Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. Onco Targets Ther 2016;9:937-43. [PMID: 26955286 DOI: 10.2147/OTT.S97824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
66 Schnitzer ML, Froelich MF, Gassert FG, Huber T, Gresser E, Schwarze V, Nörenberg D, Todica A, Rübenthaler J. Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma-A Cost-Effectiveness Analysis. Cancers (Basel) 2020;12:E2432. [PMID: 32867107 DOI: 10.3390/cancers12092432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Wertenbroek MW, Schepers M, Kamminga-Rasker HJ, Bottema JT, Muller Kobold AC, Roelofsen H, de Jong KP. Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases. BMC Cancer 2013;13:266. [PMID: 23721455 DOI: 10.1186/1471-2407-13-266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Ito F, Ku AW, Bucsek MJ, Muhitch JB, Vardam-Kaur T, Kim M, Fisher DT, Camoriano M, Khoury T, Skitzki JJ, Gollnick SO, Evans SS. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer. PLoS One. 2015;10:e0143370. [PMID: 26599402 DOI: 10.1371/journal.pone.0143370] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
69 Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S, van den Tol MP. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37:1340-7. [PMID: 23494086 DOI: 10.1007/s00268-013-1997-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
70 Huo YR, Pillai K, Akhter J, Morris DL. "Edgeboost": A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device. Cardiovasc Intervent Radiol 2016;39:97-105. [PMID: 26155781 DOI: 10.1007/s00270-015-1168-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
71 Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D'Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. Radiology. 2016;278:601-611. [PMID: 26267832 DOI: 10.1148/radiol.2015142489] [Cited by in Crossref: 165] [Cited by in F6Publishing: 163] [Article Influence: 23.6] [Reference Citation Analysis]
72 Palumbo G, De Vita E, Schena E, Massaroni C, Verze P, Carlomagno N, Tammaro V, La Rocca R, Ippolito J, Tosi D, Saccomandi P, Caponero MA, Iadicicco A, Campopiano S. Multidimensional thermal mapping during radiofrequency ablation treatments with minimally invasive fiber optic sensors. Biomed Opt Express 2018;9:5891-902. [PMID: 31065401 DOI: 10.1364/BOE.9.005891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
73 Fernández Moro C, Bozóky B, Gerling M. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review. BMJ Open Gastroenterol 2018;5:e000217. [PMID: 30073092 DOI: 10.1136/bmjgast-2018-000217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
74 Löffler MW, Nussbaum B, Jäger G, Jurmeister PS, Budczies J, Pereira PL, Clasen S, Kowalewski DJ, Mühlenbruch L, Königsrainer I, Beckert S, Ladurner R, Wagner S, Bullinger F, Gross TH, Schroeder C, Sipos B, Königsrainer A, Stevanović S, Denkert C, Rammensee HG, Gouttefangeas C, Haen SP. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer. Front Immunol 2019;10:2526. [PMID: 31803175 DOI: 10.3389/fimmu.2019.02526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
75 Sartori S, Tombesi P, Di Vece F. Thermal ablation in colorectal liver metastases: Lack of evidence or lack of capability to prove the evidence? World J Gastroenterol. 2016;22:3511-3515. [PMID: 27053843 DOI: 10.3748/wjg.v22.il3.3511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 2018;41:1189-1204. [PMID: 29666906 DOI: 10.1007/s00270-018-1959-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 15.8] [Reference Citation Analysis]
77 Brace CL, Hinshaw JL, Lubner MG. Thermal ablation for the treatment of abdominal tumors. J Vis Exp 2011:2596. [PMID: 21445029 DOI: 10.3791/2596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
78 Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619-2626. [PMID: 22431703 DOI: 10.1093/annonc/mds053] [Cited by in Crossref: 241] [Cited by in F6Publishing: 207] [Article Influence: 24.1] [Reference Citation Analysis]
79 Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207-239. [PMID: 25782566 DOI: 10.1007/s10147-015-0801-z] [Cited by in Crossref: 379] [Cited by in F6Publishing: 363] [Article Influence: 54.1] [Reference Citation Analysis]
80 Maida M, Macaluso FS, Galia M, Cabibbo G. Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report. World J Hepatol 2013; 5(12): 696-700 [PMID: 24409337 DOI: 10.4254/wjh.v5.i12.696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
81 Nachabé R, Evers DJ, Hendriks BH, Lucassen GW, van der Voort M, Wesseling J, Ruers TJ. Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples. Biomed Opt Express 2011;2:600-14. [PMID: 21412465 DOI: 10.1364/BOE.2.000600] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
82 Yun D, Kim S, Song I, Chun K. Comparative analysis of Laparoscopic versus open surgical radiofrequency ablation for malignant liver tumors. Korean J Hepatobiliary Pancreat Surg 2014;18:122-8. [PMID: 26155264 DOI: 10.14701/kjhbps.2014.18.4.122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
83 Pillai K, Akhter J, Chua TC, Shehata M, Alzahrani N, Al-Alem I, Morris DL. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore). 2015;94:e580. [PMID: 25738477 DOI: 10.1097/md.0000000000000580] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 13.4] [Reference Citation Analysis]
84 Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 2018;100:950-8. [PMID: 29485074 DOI: 10.1016/j.ijrobp.2017.12.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
85 Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W, Stroszczynski C. Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit 2012;18:CR88-92. [PMID: 22293882 DOI: 10.12659/msm.882463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
86 Au KP, Chok KSH. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm. World J Gastroenterol 2018; 24(45): 5081-5094 [PMID: 30568386 DOI: 10.3748/wjg.v24.i45.5081] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
87 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20(35): 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
88 Minami Y, Nishida N, Kudo M. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy. Eur Radiol. 2019;29:5045-5051. [PMID: 30963271 DOI: 10.1007/s00330-019-06189-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
89 Liu J, Qian LX. Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer. Exp Ther Med 2014;7:897-900. [PMID: 24669247 DOI: 10.3892/etm.2014.1505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
90 Méndez Romero A, Keskin-Cambay F, van Os RM, Nuyttens JJ, Heijmen BJM, IJzermans JNM, Verhoef C. Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy. Rep Pract Oncol Radiother 2017;22:126-31. [PMID: 28490983 DOI: 10.1016/j.rpor.2016.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
91 Zhou SW, Huang YY, Wei Y, Jiang ZM, Zhang YD, Yang Q, Xie DR. No survival benefit from adding cetuximab or panitumumab to oxaliplatin-based chemotherapy in the first-line treatment of metastatic colorectal cancer in KRAS wild type patients: a meta-analysis. PLoS One. 2012;7:e50925. [PMID: 23226426 DOI: 10.1371/journal.pone.0050925] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
92 Lentz RW, Messersmith WA. Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases. J Clin Oncol 2021;39:3887-9. [PMID: 34541862 DOI: 10.1200/JCO.21.01993] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Hamoui N, Ryu RK. Hepatic radioembolization complicated by fulminant hepatic failure. Semin Intervent Radiol 2011;28:246-51. [PMID: 22654272 DOI: 10.1055/s-0031-1280674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
94 Subramanian S, Mast TD. Optimization of tissue physical parameters for accurate temperature estimation from finite-element simulation of radiofrequency ablation. Phys Med Biol 2015;60:N345-55. [PMID: 26352462 DOI: 10.1088/0031-9155/60/19/N345] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Shi L, Chen L, Wu C, Zhu Y, Xu B, Zheng X, Sun M, Wen W, Dai X, Yang M, Lv Q, Lu B, Jiang J. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor. Clin Cancer Res 2016;22:1173-84. [PMID: 26933175 DOI: 10.1158/1078-0432.CCR-15-1352] [Cited by in Crossref: 86] [Cited by in F6Publishing: 48] [Article Influence: 14.3] [Reference Citation Analysis]
96 Wang Z, Zhang Y, Ye Y, Yao W, Xu Z, Xia Z, Wang S, Zhou C. Clinical efficacy of low-temperature radiofrequency ablation of pharyngolaryngeal cyst in 84 Chinese infants. Medicine (Baltimore) 2017;96:e8237. [PMID: 29095253 DOI: 10.1097/MD.0000000000008237] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Sartori S, Tombesi P, Di Vece F. Thermal ablation in colorectal liver metastases: Lack of evidence or lack of capability to prove the evidence? World J Gastroenterol 2016; 22(13): 3511-3515 [PMID: 27053843 DOI: 10.3748/wjg.v22.i13.3511] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
98 Tombesi P, Vece FD, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice? World J Radiol 2013; 5(1): 1-4 [PMID: 23493926 DOI: 10.4329/wjr.v5.i1.1] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
99 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
100 Xu RH, Gao W, Wang C, Guo DK, Tang L, Zhang H, Wang CJ. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis. Eur J Med Res 2014;19:39. [PMID: 25141776 DOI: 10.1186/2047-783X-19-39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
101 Franzese C, Comito T, Clerici E, Di Brina L, Tomatis S, Navarria P, Reggiori G, Viganò L, Poretti D, Pedicini V, Torzilli G, Solbiati L, Scorsetti M. Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation. J Cancer Res Clin Oncol 2018;144:1777-83. [PMID: 29934790 DOI: 10.1007/s00432-018-2692-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
102 Samim M, Prevoo W, de Wit-van der Veen BJ, Kuhlmann KF, Ruers T, van Hillegersberg R, van den Bosch MAAJ, Verkooijen HM, Lam MGEH, Stokkel MPM. 18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases. Eur J Nucl Med Mol Imaging 2017;44:1165-75. [PMID: 28180965 DOI: 10.1007/s00259-017-3637-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Egger J, Busse H, Brandmaier P, Seider D, Gawlitza M, Strocka S, Voglreiter P, Dokter M, Hofmann M, Kainz B, Hann A, Chen X, Alhonnoro T, Pollari M, Schmalstieg D, Moche M. Interactive Volumetry Of Liver Ablation Zones. Sci Rep 2015;5:15373. [PMID: 26482818 DOI: 10.1038/srep15373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
104 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
105 Singla S, Hochwald SN, Kuvshinoff B. Evolving ablative therapies for hepatic malignancy. Biomed Res Int 2014;2014:230174. [PMID: 24877069 DOI: 10.1155/2014/230174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
106 Cacciola A, Parisi S, Tamburella C, Lillo S, Ferini G, Molino L, Iatì G, Pontoriero A, Bottari A, Mazziotti S, Cicero G, Minutoli F, Blandino A, Pergolizzi S. Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Rep Pract Oncol Radiother 2020;25:299-306. [PMID: 32194349 DOI: 10.1016/j.rpor.2020.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Voglreiter P, Mariappan P, Pollari M, Flanagan R, Blanco Sequeiros R, Portugaller RH, Fütterer J, Schmalstieg D, Kolesnik M, Moche M. RFA Guardian: Comprehensive Simulation of Radiofrequency Ablation Treatment of Liver Tumors. Sci Rep 2018;8:787. [PMID: 29335429 DOI: 10.1038/s41598-017-18899-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
108 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
109 Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol 2019;10:1274-98. [PMID: 31949948 DOI: 10.21037/jgo.2019.08.06] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
110 Lalmahomed ZS, Mostert B, Onstenk W, Kraan J, Ayez N, Gratama JW, Grünhagen D, Verhoef C, Sleijfer S. Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases. Br J Cancer. 2015;112:556-561. [PMID: 25562435 DOI: 10.1038/bjc.2014.651] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
111 Veltri A, Gazzera C, Rotondella C, Camerano F, Busso M, Gandini G. Image-guided microwave ablation of hepatic tumours: preliminary experience. Radiol Med 2012;117:378-92. [PMID: 22095414 DOI: 10.1007/s11547-011-0745-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
112 Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH. Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort. Onco Targets Ther 2016;9:3783-9. [PMID: 27382314 DOI: 10.2147/OTT.S105192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
113 路娜, 王雅棣. 局部治疗手段在结直肠癌肝转移治疗中的价值. 世界华人消化杂志 2017; 25(19): 1705-1713 [DOI: 10.11569/wcjd.v25.i19.1705] [Reference Citation Analysis]
114 Tanaka T, Kaida T, Yokoi K, Ishii S, Nishizawa N, Kawamata H, Katoh H, Sato T, Nakamura T, Watanabe M, Yamashita K. Critical relevance of genomic gains of PRL-3/EGFR/c-myc pathway genes in liver metastasis of colorectal cancer. Oncol Lett 2019;17:1257-66. [PMID: 30655893 DOI: 10.3892/ol.2018.9728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
115 Kwan SW, Kerlan RK Jr, Sunshine JH. Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol 2010;21:1054-60. [PMID: 20478718 DOI: 10.1016/j.jvir.2010.02.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
116 Solorio L, Wu H, Hernandez C, Gangolli M, Exner AA. Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model. Ther Deliv 2016;7:201-12. [PMID: 27010983 DOI: 10.4155/tde-2015-0008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
117 Hazhirkarzar B, Khoshpouri P, Shaghaghi M, Ghasabeh MA, Pawlik TM, Kamel IR. Current state of the art imaging approaches for colorectal liver metastasis. Hepatobiliary Surg Nutr 2020;9:35-48. [PMID: 32140477 DOI: 10.21037/hbsn.2019.05.11] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
118 Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg 2011; 3(12): 183-196 [PMID: 22224173 DOI: 10.4240/wjgs.v3.i12.183] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
119 Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol. 2010;27:285-295. [PMID: 22550368 DOI: 10.1055/s-0030-1261787] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
120 Nielsen K, Scheffer HJ, Pieters IC, van Tilborg AA, van Waesberghe JH, Oprea-Lager DE, Meijerink MR, Kazemier G, Hoekstra OS, Schreurs HW, Sietses C, Meijer S, Comans EF, van den Tol PM. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases. BMC Med Imaging. 2014;14:27. [PMID: 25103913 DOI: 10.1186/1471-2342-14-27] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
121 Mitin T, Enestvedt CK, Thomas CR Jr. Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol 2015;6:201-7. [PMID: 25830039 DOI: 10.3978/j.issn.2078-6891.2014.086] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
122 Schumann C, Rieder C, Haase S, Teichert K, Süss P, Isfort P, Bruners P, Preusser T. Interactive multi-criteria planning for radiofrequency ablation. Int J Comput Assist Radiol Surg 2015;10:879-89. [PMID: 25903775 DOI: 10.1007/s11548-015-1201-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
123 Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M. Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 2012;17:1100-7. [PMID: 22723509 DOI: 10.1634/theoncologist.2012-0092] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 12.3] [Reference Citation Analysis]
124 Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 2011;98:1003-9. [PMID: 21541936 DOI: 10.1002/bjs.7506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
125 Eng OS, Tsang AT, Moore D, Chen C, Narayanan S, Gannon CJ, August DA, Carpizo DR, Melstrom LG. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J Surg Oncol. 2015;111:410-413. [PMID: 25557924 DOI: 10.1002/jso.23849] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
126 Wang J, Liang P, Yu J, Yu MA, Liu F, Cheng Z, Yu X. Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases. Oncol Lett 2014;8:323-6. [PMID: 24959270 DOI: 10.3892/ol.2014.2106] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
127 Choti MA. Liver-directed treatments for metastatic colorectal cancer. Curr Treat Options Oncol 2014;15:456-64. [PMID: 24952016 DOI: 10.1007/s11864-014-0297-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
128 Facciorusso A, Del Prete V, Crucinio N, Serviddio G, Vendemiale G, Muscatiello N. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. World J Gastroenterol 2016; 22(16): 4211-4218 [PMID: 27122671 DOI: 10.3748/wjg.v22.i16.4211] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
129 Ao T, Kajiwara Y, Yonemura K, Shinto E, Mochizuki S, Okamoto K, Aosasa S, Ueno H. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases. Virchows Arch 2019;475:341-8. [PMID: 31076902 DOI: 10.1007/s00428-019-02580-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
130 Bale R, Widmann G, Schullian P, Haidu M, Pall G, Klaus A, Weiss H, Biebl M, Margreiter R. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol. 2012;22:930-937. [PMID: 22071776 DOI: 10.1007/s00330-011-2314-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
131 Tan HL, Lee M, Vellayappan BA, Neo WT, Yong WP. The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep. 2018;14:129-137. [PMID: 30294248 DOI: 10.1007/s11888-018-0409-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
132 Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol 2019;4:142-9. [PMID: 30706022 DOI: 10.1016/j.adro.2018.08.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
133 Swaid F, Tsung A. Current Management of Liver Metastasis From Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:12-21. [DOI: 10.1007/s11888-018-0397-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Wust P, Beck M, Dabrowski R, Neumann O, Zschaeck S, Kaul D, Modest DP, Stromberger C, Gebauer B, Ghadjar P. Radiotherapeutic treatment options for oligotopic malignant liver lesions. Radiat Oncol 2021;16:51. [PMID: 33726751 DOI: 10.1186/s13014-021-01779-5] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
135 van Amerongen MJ, Mariappan P, Voglreiter P, Flanagan R, Jenniskens SFM, Pollari M, Kolesnik M, Moche M, Fütterer JJ. Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors. Int J Comput Assist Radiol Surg 2021;16:1051-7. [PMID: 33974224 DOI: 10.1007/s11548-021-02394-1] [Reference Citation Analysis]
136 Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol. 2016;34:452-459. [PMID: 26628466 DOI: 10.1200/jco.2015.61.4925] [Cited by in Crossref: 259] [Cited by in F6Publishing: 112] [Article Influence: 37.0] [Reference Citation Analysis]
137 Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin TC. Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford) 2013;15:365-71. [PMID: 23458599 DOI: 10.1111/j.1477-2574.2012.00585.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
138 Takahashi H, Berber E. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg Nutr 2020;9:49-58. [PMID: 32140478 DOI: 10.21037/hbsn.2019.06.08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
139 Hsia HH, Xiong N. Infusion Needle Ablation Catheter: An Evolution of Needs. J Am Coll Cardiol 2019;73:1426-9. [PMID: 30922473 DOI: 10.1016/j.jacc.2018.12.069] [Reference Citation Analysis]
140 Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017;109. [PMID: 28376151 DOI: 10.1093/jnci/djx015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 192] [Article Influence: 39.4] [Reference Citation Analysis]
141 Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. Stereotactic body radiation therapy for primary and metastatic liver tumors. Transl Oncol. 2013;6:442-446. [PMID: 23908687 DOI: 10.1593/tlo.12448] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
142 Govaert KM, van Kessel CS, Steller EJ, Emmink BL, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH. Recurrence location after resection of colorectal liver metastases influences prognosis. J Gastrointest Surg 2014;18:952-60. [PMID: 24474631 DOI: 10.1007/s11605-014-2461-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
143 Zhang SY, Zhu GY, Li G, Zhang YB, Geng JH. Application of stereotactic body radiation therapy to cancer liver metastasis. Cancer Lett 2016;379:225-9. [PMID: 26704306 DOI: 10.1016/j.canlet.2015.10.029] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]